Mira Pharmaceuticals
By A Mystery Man Writer
Description
Mira Pharmaceuticals | 1,002 followers on LinkedIn. Developing the next-generation FDA-approved novel synthetic THC analog | MIRA1a is being developed to treat anxiety and cognitive decline in the elderly and neuropathic pain without impurities or the adverse side effects of cannabis plant extracts.
Mira Pharmaceuticals Files For $16m IPO - Business of Cannabis
Edward Tsuker posted on LinkedIn
Mira Pharmaceuticals Inc
Mira Pharmaceuticals
MIRA Pharmaceuticals, Inc. (MIRA) Stock Price, Quote & News - Stock Analysis
MIRA Pharmaceuticals, Inc. (MIRA) Stock Price, Quote & News - Stock Analysis
formdrsa_016.jpg
Mira1a: A New Breakthrough in the World of Pharmaceutical Cannabinoids - Cannabis Tech
Pharmaceutical Contract Manufacturing In Mira Bhayandar - Prices, Manufacturers & Suppliers
Erez Aminov - Chief Executive Officer at Mira Pharmaceuticals, Inc.
from
per adult (price varies by group size)
